NASOPHARYNGEAL CANCER METASTATIC

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting NASOPHARYNGEAL CANCER METASTATIC:

# Drug Count
0 DENOSUMAB 4
1 EVEROLIMUS 3
2 EVEROLIMUS TABLETS 3
3 NIVOLUMAB 3
4 ASCIMINIB 1
5 CIPROFLOXACIN 1
6 CIPROFLOXACIN HYDROCHLORIDE 1
7 CIPROFLOXACIN TABLETS 1
8 CIPROFOLXACIN 1
9 DOCETAXEL 1
See all common drugs associated with NASOPHARYNGEAL CANCER METASTATIC

NASOPHARYNGEAL CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 1 0.0019
1 ASCIMINIB 1 0.0003
2 EVEROLIMUS TABLETS 3 0.0002
3 PEGFILGRASTIM 1 0.0001
4 EVEROLIMUS 3 0.0001
5 OLAPARIB 1 0.0000
6 PAZOPANIB HYDROCHLORIDE 1 0.0000
7 NIVOLUMAB 3 0.0000
8 DENOSUMAB 4 0.0000
9 DOCETAXEL 1 0.0000
See all drugs enriched for association with NASOPHARYNGEAL CANCER METASTATIC